GlassScriptPhysician profile
Abigail Toothman Hoyle
NPI 1679094759
$3,853.34
in general payments reported to CMS, 2019-2025
26 companies · $889 in 2025
The $889 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $70.52 · 2022: $227 · 2023: $2,160 · 2024: $507 · 2025: $889.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,950 · Education: $1,600 · Travel and Lodging: $6.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,949.86 |
| Education | $1,599.99 |
| Travel and Lodging | $6.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,599.79 | 2023 | Davinci Xi, Da Vinci Surgical System |
| Astellas Pharma US INC | $345.34 | 2022-2025 | Veozah |
| Sage Therapeutics, LLC | $335.72 | 2024-2025 | Zurzuvae |
| Organon LLC | $246.50 | 2022-2025 | Nexplanon, Jada System |
| Sumitomo Pharma America, INC. | $139.08 | 2023-2025 | Gemtesa, Myfembree |
| Novo Nordisk INC | $112.62 | 2021-2025 | Wegovy |
| Mayne Pharma Commercial LLC | $111.37 | 2024-2025 | |
| Shield Therapeutics INC | $111.30 | 2023-2024 | Accrufer |
| Daiichi Sankyo INC. | $110.80 | 2022-2024 | Injectafer |
| Amgen INC. | $103.30 | 2022-2025 | Evenity |
| Exeltis, USA INC. | $77.36 | 2022-2024 | Slynd |
| Pfizer INC. | $77.03 | 2021-2025 | |
| Exact Sciences Corporation | $70.55 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Abbvie INC. | $53.53 | 2023-2025 | |
| Agile Therapeutics, INC. | $53.18 | 2022-2023 | Twirla |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $47.78 | 2022-2024 | Paragard T 380a, Paragard T 380a |
| Ethicon US, LLC | $44.66 | 2023-2025 | Ethicon, Vicryl |
| Axonics, INC. | $35.09 | 2023-2024 | Axonics, Bulkamid |
| Millicent US INC | $33.78 | 2025 | Intrarosa, Femlyv |
| Bayer Healthcare Pharmaceuticals INC. | $33.50 | 2025 | |
| Si-Bone, INC. | $31.15 | 2023 | |
| Merck Sharp & Dohme LLC | $20.17 | 2025 | Gardasil 9 |
| Vivus LLC | $16.00 | 2021 | |
| Therapeuticsmd, INC. | $15.78 | 2021 | |
| Almatica Pharma LLC | $14.74 | 2022 | |
| Hologic Sales and Service, LLC | $13.22 | 2024 | Myosure Tissue Removal Device, Fluent Fluid Management System, Novasure |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abigail Toothman Hoyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.